Inflammation and Overweight in Peritoneal Dialysis: Is There an Association?

REFERENCES

• Chung SH, Heimburger O, Stenvinkel P, Rashid A, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003; 18: 590–597
   PubMedGoogle Scholar
• Ávila-Díaz M, Ventura M, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int. 2006; 26: 574–580
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Barany P, Linholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002; 17: 1684–1688
   PubMed Web of Science ®Google Scholar
• Cueto-Manzano AM, González-Espínoza L, Campo FM, Fortes PC, Pecoits-Filho R. Inflammation in peritoneal dialysis: A Latin-American perspective. Perit Dial Int. 2007; 27: 347–352
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. BJN. 2004; 92: 347–355
   PubMed Web of Science ®Google Scholar
• Pennell P, Rojas C, Asif A, Rossini E. Managing metabolic complications of peritoneal dialysis. Clin Nephrol. 2004; 62: 35–43
   PubMed Web of Science ®Google Scholar
• Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive weight gain during peritoneal dialysis. Int J Artif Organs. 2001; 24: 197–202
   PubMedGoogle Scholar
• McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003; 14: 2894–2901
   PubMed Web of Science ®Google Scholar
• Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int. 2005; 25: 461–469
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005; 81: 543–554
   PubMed Web of Science ®Google Scholar
• Mafra D, Farage NE. O papel do tecido adiposo na doença renal crônica. J Bras Nefrol. 2006; 28: 108–113
   Google Scholar
• Beddhu A, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003; 14: 2366–2372
   PubMed Web of Science ®Google Scholar
• Durnin JVGA, Womersley J. Body fat assessment from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged 16 to 72 years. Br J Nutr. 1974; 32: 77–97
   PubMed Web of Science ®Google Scholar
• Siri WE. Body composition from fluid spaces and density: Analysis of methods. University of California Radiation Laboratory publication 3349. Pitman, Berkeley, Calif 1956
   Google Scholar
• Grant JP, Custer PB, Thurlow J. Current techniques of nutritional assessment. Surg Clin North Am. 1981; 61: 463–473
   Google Scholar
• Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34: 2540–2545
   PubMed Web of Science ®Google Scholar
• NKF/KDOQI. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000; 35: S17
   Google Scholar
• Kalantar-Zadeh K, Block G, McAllister CJ, Humpreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004; 80: 299–307
   PubMed Web of Science ®Google Scholar
• Chandalia M, Abate N. Metabolic complications of obesity: Inflated or inflamed?. J Diabetes Complications. 2007; 21: 128–136
   PubMed Web of Science ®Google Scholar
• Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?. J Am Soc Nephrol. 2003; 14: 1871–1879
   PubMed Web of Science ®Google Scholar
• Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282: 2131–2135
   PubMed Web of Science ®Google Scholar
• Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, Pergola G. C- reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes. 2001; 25: 1416–1420
   PubMed Web of Science ®Google Scholar
• Axelsson J, Qureshi AR, Suliman ME, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr. 2004; 80: 1222–1229
   PubMed Web of Science ®Google Scholar
• Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 2003; 64: 1838–1844
   PubMed Web of Science ®Google Scholar
• Fried L, Bernardini J, Piraino B. Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int. 1996; 16: 357–361
   PubMedGoogle Scholar
• Aslam N, Bernardini J, Fried L, Piraino B. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int. 2002; 22: 191–196
   PubMedGoogle Scholar
• Carvounis CP, Manis T, Coritsidis G, Dubinski M, Serpente P. Total lymphocyte count: A promising prognostic index of mortality in patients on CAPD. Perit Dial Int. 2000; 20: 33–38
   PubMed Web of Science ®Google Scholar
• Ates K, Ates A, Kutlay S, Nergizogi G, Karatan O. Total lymphocyte count in peripheral blood of peritoneal dialysis patients: Relationship to clinical parameters and outcome. J Nephrol. 2004; 17: 246–252
   PubMed Web of Science ®Google Scholar
• Reddan DN, Klassen PS, Szczech LA, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 1167–1173
   PubMed Web of Science ®Google Scholar
• Sayarlioglu H, Erkoc R, Demir C, et al. Nutritional status and immune functions in maintenance hemodialysis patients. Mediators Inflamm. 2006; 2006: 1–4
   Google Scholar
• Lacson E, Jr, Levin NW. C-reactive protein and end-stage renal disease. Semin Dial. 2004; 17: 438–448
   PubMed Web of Science ®Google Scholar
• Bulló M, Garcia-Lorda P, Megias I, Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003; 11: 525–531
   PubMedGoogle Scholar
• Zoccalli C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Perlongo S. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13: 134–141
   PubMedGoogle Scholar
• Malyszko J, Malysko J, Wolczynski S, Mysliwiec M. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: Are they related?. Nephrol Dial Transplant. 2006; 21: 145–152
   PubMed Web of Science ®Google Scholar
• Guebre-Egziabher F, Drai J, Fouque D. Adiponectin and chronic kidney disease. J Ren Nutr. 2007; 17: 9–12
   PubMedGoogle Scholar
• Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in hemodialysis patients. Nephrol Dial Transplant. 2004; 19: 141–149
   PubMed Web of Science ®Google Scholar